UNSPSC 51281676: Telavancin hydrochloride

This classification denotes an antimicrobial solution, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0701472ZG0. European Medicines Agency schedules Telavancin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35005. Telavancin hydrochloride generally arises in the molecular formula C80H106CL2N11O27P.CLH. The term 'telavancin hydrochloride' is a United States Adopted Name designation.

Most nations, for tariff and trade purposes, schedule telavancin hydrochloride under HS 29419000 and SITC 54139. Telavancin hydrochloride bears US NLM identifiers UMLS ID C2730005 and NCI Concept Code C87636. SMILES: As of Q4 2014, TELAVANCIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

UNSPSC 51281676 Telavancin hydrochloride, a Commodity code, shows limited alignment between its nominal scope—a specific antimicrobial pharmaceutical—and recent state and local solicitations tagged under it. The opportunities that do appear under this code involve broader medical and pharmaceutical procurement: emergency medical supplies for fire departments, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, direct-to-manufacturer pharmacy programs, and naloxone with drug deactivation systems. State and local agencies issuing under this code span county health departments (Seminole County, Florida), state HHS commissions (Texas), municipal fire services (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local facilities including Oregon). None of the recent opportunities are actually for telavancin hydrochloride as a discrete product line.

Recent activity includes the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products posted January 20, 2026, with a response deadline of March 26, 2026, seeking manufacturers to supply through three authorized wholesalers with awards effective July 1, 2026; the City of Tampa's IFB for medical and first aid supplies posted March 25, 2026 (due March 13, 2026) for the Tampa Fire Department Rescue Division, an estimated $700,000 contract sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; and Seminole County, Florida's IFB posted June 30, 2026 (due July 26, 2023) for naloxone and safe drug deactivation systems. The Texas HHS Commission also posted an RFI on April 3, 2026, seeking vendor capabilities for a direct-to-manufacturer prescription program. Geographic concentration appears light, with identifiable recent activity in Florida, Texas, Minnesota, and Oregon, though the code's sparse alignment with its nominal scope suggests it may be mislabeled or underutilized in current state and local procurement activity.